The adoption of GLP-1 drugs for weight loss is exerting noticeable pressure on the food industry, driving changes in consumer behavior and dietary preferences
Our work includes: Regulatory risk assessments for RUO and peptide suppliers FDA compliance analysis Intellectual property exposure review Business restructuring and product line pivots Counseling on exit strategies from high-risk markets We do not rely on outdated assumptions
The majority of patients will not develop biliary disease, and the risks of unnecessary surgery outweigh the population-level benefit
Satiable curiosity and love of science to keep asking questions, digging for answers and sharing the information that I uncover with as many people as I can
The authors found the glucose infusion rate (GIR) during the clamp study decreased with OXM compared with OXMQ3E in wild-type mice, likely due to increased hepatic glucose output from GCGR agonism with OXM
This mechanism reduces appetite and helps control calorie intake effectively without drastic dieting